METODO DI BELLA
>
INDICE DELLA DOCUMENTAZIONE > DOCUMENTAZIONE SCIENTIFICA
DOCUMENTAZIONE SCIENTIFICA
All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein.
(13/04/2011)
Dettaglio
Retinoids, retinoic acid receptors, and cancer.
(13/04/2011)
Dettaglio
Uptake of all-trans retinoic acid-containing aerosol by inhalation to lungs in a guinea pig model system--a pilot study.
(13/04/2011)
Dettaglio
Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth.
(13/04/2011)
Dettaglio
The effect of differentiating and apoptotic agents on notch signalling pathway in hepatoblastoma.
(13/04/2011)
Dettaglio
A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
(13/04/2011)
Dettaglio
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats.
(13/04/2011)
Dettaglio
PTOV1 antagonizes MED25 in RAR transcriptional activation.
(13/04/2011)
Dettaglio
Retinoic acid receptor modulators: a perspective on recent advances and promises.
(13/04/2011)
Dettaglio
Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
(13/04/2011)
Dettaglio
Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets.
(13/04/2011)
Dettaglio
Plasma antioxidant concentration, not superoxide dismutase polymorphism, is associated with breast cancer risk in Korean women.
(13/04/2011)
Dettaglio
Inverse agonists and antagonists of retinoid receptors.
(13/04/2011)
Dettaglio
p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.
(13/04/2011)
Dettaglio
Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab.
(13/04/2011)
Dettaglio